Recent advances in the genetics of dementia with lewy bodies

Curr Neurol Neurosci Rep. 2008 May;8(3):187-9. doi: 10.1007/s11910-008-0030-1.

Abstract

In the past few years, mutations have been identified in the genes encoding alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in some patients with dementia with Lewy bodies (DLB). Furthermore, a novel locus for familial DLB has been mapped to chromosome 2q35-q36. Collectively, these discoveries highlight a substantial overlap between the known genetic determinants of Parkinson's disease and DLB, as well as the presence of profound etiologic heterogeneity in Lewy body disorders.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Glucosylceramidase / genetics*
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Lewy Body Disease / genetics*
  • Mutation*
  • Protein Serine-Threonine Kinases / genetics*
  • alpha-Synuclein / genetics*

Substances

  • alpha-Synuclein
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases
  • Glucosylceramidase